Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays
In addition to dermatological complications, acne can affect the quality of life of individuals in numerous ways, such as employment, social habits and body dissatisfaction. According to our expertise, caprylic acid and propanediol would not have a direct action on <i>Cutibacterium acnes</i...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18ac208429184b9b89ced7395dc33c53 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:18ac208429184b9b89ced7395dc33c53 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:18ac208429184b9b89ced7395dc33c532021-11-11T18:39:08ZPropanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays10.3390/molecules262167041420-3049https://doaj.org/article/18ac208429184b9b89ced7395dc33c532021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6704https://doaj.org/toc/1420-3049In addition to dermatological complications, acne can affect the quality of life of individuals in numerous ways, such as employment, social habits and body dissatisfaction. According to our expertise, caprylic acid and propanediol would not have a direct action on <i>Cutibacterium acnes</i>. Despite this, we investigated the existence of a synergistic effect among xylitol, caprylic acid and propanediol as a mixture of compounds representing a single topical active ingredient that could benefit the treatment against acne. In vitro and in vivo assays were performed to challenge and to prove the efficacy of propanediol, xylitol and caprylic acid (PXCA) against acne. PXCA had its MIC challenged against <i>C. acnes</i> (formerly <i>Propionibacterium acnes</i>) and <i>Staphylococcus aureus</i>, resulting in concentrations of 0.125% and 0.25%, respectively, and it also developed antimicrobial activity against <i>C. acnes</i> (time-kill test). PXCA was able to reduce the 5-alpha reductase expression in 24% (<i>p</i> < 0.01) in comparison with the testosterone group. By the end of 28 days of treatment, the compound reduced the skin oiliness, porphyrin amount and the quantity of inflammatory lesions in participants. According to the dermatologist evaluation, PXCA improved the skin’s general appearance, acne presence and size.Lilian MussiAndré Rolim BabyFlavio Bueno Camargo JuniorGiovana PadovaniBianca da Silva SufiWagner Vidal MagalhãesMDPI AGarticleacnexylitolcaprylic acidpropanediolporphyrin5-alpha reductaseOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6704, p 6704 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
acne xylitol caprylic acid propanediol porphyrin 5-alpha reductase Organic chemistry QD241-441 |
spellingShingle |
acne xylitol caprylic acid propanediol porphyrin 5-alpha reductase Organic chemistry QD241-441 Lilian Mussi André Rolim Baby Flavio Bueno Camargo Junior Giovana Padovani Bianca da Silva Sufi Wagner Vidal Magalhães Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays |
description |
In addition to dermatological complications, acne can affect the quality of life of individuals in numerous ways, such as employment, social habits and body dissatisfaction. According to our expertise, caprylic acid and propanediol would not have a direct action on <i>Cutibacterium acnes</i>. Despite this, we investigated the existence of a synergistic effect among xylitol, caprylic acid and propanediol as a mixture of compounds representing a single topical active ingredient that could benefit the treatment against acne. In vitro and in vivo assays were performed to challenge and to prove the efficacy of propanediol, xylitol and caprylic acid (PXCA) against acne. PXCA had its MIC challenged against <i>C. acnes</i> (formerly <i>Propionibacterium acnes</i>) and <i>Staphylococcus aureus</i>, resulting in concentrations of 0.125% and 0.25%, respectively, and it also developed antimicrobial activity against <i>C. acnes</i> (time-kill test). PXCA was able to reduce the 5-alpha reductase expression in 24% (<i>p</i> < 0.01) in comparison with the testosterone group. By the end of 28 days of treatment, the compound reduced the skin oiliness, porphyrin amount and the quantity of inflammatory lesions in participants. According to the dermatologist evaluation, PXCA improved the skin’s general appearance, acne presence and size. |
format |
article |
author |
Lilian Mussi André Rolim Baby Flavio Bueno Camargo Junior Giovana Padovani Bianca da Silva Sufi Wagner Vidal Magalhães |
author_facet |
Lilian Mussi André Rolim Baby Flavio Bueno Camargo Junior Giovana Padovani Bianca da Silva Sufi Wagner Vidal Magalhães |
author_sort |
Lilian Mussi |
title |
Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays |
title_short |
Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays |
title_full |
Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays |
title_fullStr |
Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays |
title_full_unstemmed |
Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays |
title_sort |
propanediol (and) caprylic acid (and) xylitol as a new single topical active ingredient against acne: in vitro and in vivo efficacy assays |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/18ac208429184b9b89ced7395dc33c53 |
work_keys_str_mv |
AT lilianmussi propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays AT andrerolimbaby propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays AT flaviobuenocamargojunior propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays AT giovanapadovani propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays AT biancadasilvasufi propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays AT wagnervidalmagalhaes propanediolandcaprylicacidandxylitolasanewsingletopicalactiveingredientagainstacneinvitroandinvivoefficacyassays |
_version_ |
1718431748720689152 |